Allotment of 38,71,854 (Thirty Eight Lakh Seventy One Thousand Eight Hundred Fifty Four) fully paid-up equity shares of face value of ?10/- (Rupees Ten Only) each ('Equity Shares') at an issue price of ?40/- (Rupees Forty Only) per Equity Share, including a premium of ?30/- (Rupees Thirty Only) per Equity Share, aggregating to ?15,48,74,160/- (Rupees Fifteen Crore Forty Eight Lakh Seventy Four Thousand One Hundred and Sixty Only), on a preferential ....

Date: 24th October, 2026 The Secretary, Listing Department Bombay Stock Exchange Ltd Phiroze Jeejeebhoy Towers, Street, Mumbai – 400 001 Reference: Scrip Code: 524723/ ISIN: INE491D01017 Subject: Outcome of Meeting of Board of Directors of Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) (“the Company”) in accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 (“Listing Regulation”) Respected Authorities, This is in furtherance to the Board Meeting held on Saturday, July 11, 2026 and the outcome thereof, as well as the subsequent approval granted by the shareholders through postal ballot dated 13th August 2026 for the issuance of equity shares on a preferential basis for consideration other than cash, in accordance with the applicable provisions of the Companies Act, 2013 (“the Act”), and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 for which In Principle Approval has been received from BSE Limited vide Letter No. LOD/PREF/KS/FIP/920/2026- 27 dated October 12, 2026. Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), We further wish to inform you that the Board of the Directors of the Company at their meeting held today i.e. Saturday, October 24, 2026 through requisite majority has considered and approved: 1. Allotment of 38,71,854 (Thirty Eight Lakh Seventy One Thousand Eight Hundred Fifty Four) fully paid-up equity shares of face value of ₹10/- (Rupees Ten Only) each (“Equity Shares”) at an issue price of ₹40/- (Rupees Forty Only) per Equity Share, including a premium of ₹30/- (Rupees Thirty Only) per Equity Share, aggregating to ₹15,48,74,160/- (Rupees Fifteen Crore Forty Eight Lakh Seventy Four Thousand One Hundred and Sixty Only), on a preferential allotment basis through private placement to the shareholders of Sushodha Institute of Gastroenterology Private Limited (“SIGPL”), for consideration other than cash, on a share swap basis. The list of allottees is attached as “Annexure A”. Consequent to the aforesaid allotment of 38,71,854 (Thirty Eight Lakh Seventy One Thousand Eight Hundred Fifty Four) equity shares; the paid-up equity capital of the Company has increased from Rs. 48,02,18,570/- (Rupees Forty Eight Crore Two Lakhs Eighteen Thousand Five Hundred Seventy only) consisting of 4,80,21,857 (Four Crores Eighty Lakhs Twenty One Thousand Eight Hundred Fifty Seven) equity shares of 10/- each to Rs. 51,89,37,110/- (Rupees Fifty One Crore Eighty Nine Lakh Thirty Seven Thousand One Hundred and Ten only) consisting of 5,18,93,711 (Five Crore Eighteen Lakh Ninety Three Thousand Seven Hundred and Eleven) equity shares of Rs.10/- each. The Company will be making an application to the stock exchanges for listing and trading approval for the newly allotted shares in due course. The New Equity shares allotted on the preferential allotment basis shall rank pari-passu with the existing equity shares of the Company in all respects. The Equity Shares allotted on preferential basis shall be locked-in for specified period in compliance with the provisions of Chapter VII of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018. The above information is also being made available on the website of the Company at https://www.arvayahealth.com The disclosures as required under regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 are enclosed as “Annexure - B”. The meeting of Board of Directors of the Company commenced at 3.30 p.m. and concluded at 5:30 p.m. We request you to take the above on record and the same be treated as compliance under the applicable provisions of the SEBI Listing Regulations. Thanking you, Yours faithfully, For and on Behalf of Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) Kaushal Uttam Shah Managing Director DIN: 02175130 Place: Pune Date: 24th October 2026 Place: Pune ANNEXURE A: LIST OF EQUITY SHARES ALLOTTED S. No. Name of the Allottee Category No. of Equity shares to be allotted 1 J K Pradeepkumar Non - Promoter 1328124 2 B K Anilkumar Non - Promoter 591129 3 Ambika S Chiniwalar Non - Promoter 25305 4 Arun Kumar Jeedi Non - Promoter 63273 5 Chandrashekhar Byadgi Non - Promoter 25305 6 Kavita Bhairi Non - Promoter 25305 7 Rudresh Tabali Non - Promoter 63273 8 Saroja S Bhairi Non - Promoter 75936 9 SL Manasa Non - Promoter 63273 10 Jyoti Jambaladinni Non - Promoter 25305 11 Mankani Navin Hanamanthreddi Non - Promoter 12663 12 Mohan Vijapur Non - Promoter 25305 13 N Goravar Non - Promoter 25305 14 Padmashree K Non - Promoter 27846 15 Parithosh Jayanthi Non - Promoter 88578 16 R Manikya Non - Promoter 31626 17 Sapan D S Non - Promoter 12663 18 Reena Biradar Non - Promoter 25305 19 Rajeshwari M Non - Promoter 25305 20 Ravi Prasad Non - Promoter 63273 21 Shrikant S Ramanagoudar Non - Promoter 12663 22 Vinay Pawar Non - Promoter 31626 23 Sneha Vikranth Dharamshi Non - Promoter 37968 24 Sowmya G S Non - Promoter 63273 25 Vishwanath M Patil Non - Promoter 12663 26 Vishwas D Pai Non - Promoter 63273 27 Virendra Bhasme Non - Promoter 31626 28 Vishwanath S Non - Promoter 25305 29 Jayaraj Patil Non - Promoter 50610 30 Ashwin Shrigopal Marda Non - Promoter 5061 31 Marda Abhishek Shrigopal Non - Promoter 5061 32 Pratyush Yogesh Goyal Non - Promoter 12663 33 Yogesh Goyal (HUF) Non - Promoter 37968 34 Vinod Nawandhar Non - Promoter 63273 35 Harjiv Singh Swani Non - Promoter 25305 36 Rajesh Udhaudas Moorjani Non - Promoter 63273 37 AKB Enterprises Non - Promoter 101241 38 Gopalkrishnan Vijayaraghavan Non - Promoter 12663 39 Sanjeev V Chintamani Non - Promoter 63273 40 Dhanaji Dattatray Jadhav Non - Promoter 151851 41 Charu Bansal Non - Promoter 101241 42 Yogesh Laxman Rajhans Non - Promoter 70875 43 Jalpa Darshan Shah Non - Promoter 70875 44 Anandrao Nanaso Ghadge Non - Promoter 20244 45 Priyadarshini R.E. Non - Promoter 25305 46 Ramappa Huchchappa Doddamani Non - Promoter 50610 47 Srinivasa Appasani Non - Promoter 37968 Total Equity Shares 38,71,854 ANNEXURE -B Disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular no. SEBI/HO/CFD/CFD- PoD1/P/CIR/2023/123 dated July 13, 2023 on allotment of Equity Shares Sr. Particulars Details 1. Types of securities proposed to be 38,71,854 Equity Shares of Rs 10/- each fully paid up Issued 2. Type of issuance (further public Preferential issue of equity shares in accordance with offering, rights issue, depository the Securities and Exchange Board of India (Issue of receipts (ADR/GDR), qualified Capital and Disclosure Requirements) Regulations, institutions placement, 2018 (“ICDR Regulations”), read with the Companies preferential allotment etc.) Act, 2013 and rules made thereunder. 3. Total number of Allotment of 38,71,854 (Thirty Eight Lakh Seventy One Securities proposed to be issued or Thousand Eight Hundred Fifty Four) equity shares of the total amount for which the the Company having face value of Rs. 10/- (Rupee Ten securities will be issued Only) each, which is not less than the price determined in accordance with Chapter V of the ICDR Regulations, for consideration other than cash. Additional details i. Names of the investors As per Annexure A ii. No. of Investors 47 iii. Post allotment of securities - Equity shares allotted on preferential basis for outcome of the subscription, consideration other than cash issue price / allotted price (in case of convertibles), number of investors iv. Issue Price Issue at a price of Rs. ₹40/- per Equity Share (Rupees Forty Only) including a premium of ₹ 30/- (Rupees Thirty Only) per Equity Share aggregating to ₹ 15,48,74,160/- (Rupees Fifteen Crore Forty Eight Lakh Seventy Four Thousand One Hundred and Sixty On [Showing first 8,000 characters — download PDF for full document]